Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P-glycoprotein mediated vincristine resistance of L1210 cells

被引:0
作者
Kisucká, J
Barancík, M
Bohácová, V
Breier, A
机构
[1] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia
[2] Slovak Acad Sci, Heart Res Inst, Bratislava 84233, Slovakia
关键词
P-glycoprotein; multidrug resistance; extracellular-signal regulated protein kinases inhibitors; vincristine; L1210; cells;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Effect of specific inhibitors of extracellular-signal regulated protein kinase (ERK) pathway, PD98059 and UO126, on P-glycoprotein (Pgp)-mediated vincristine resistance of L1210/VCR cells was investigated. Both test inhibitors significantly reduced the survival of L1210/VCR cells in the presence of vincristine and this was associated with a decrease of LC50 values to vincristine from 2.65 +/- 0.43 to 0.67 +/- 0.28 mumol/l and to 0.69 +/- 0.09 mumol/l after treatment with 50 mumol/l PD98059 and 25 mumol/l UO126, respectively. Moreover, the effects of PD98059 are connected also with an increased intra,cellular accumulation of radiolabeled vincristine in resistant L1210/VCR cells in concentration dependent manner. The results of this study demonstrate that inhibitors of ERK signaling pathway are reversal agents of vincristine resistance in L1210/VCR cells. The precise mechanism of PD98059 and UO126 action in modulation of MDR is not resolved yet, but the role of ERK-mediated phosphorylation cascade could be considered.
引用
收藏
页码:439 / 444
页数:6
相关论文
共 22 条
  • [1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [2] Barancík M, 1999, GEN PHYSIOL BIOPHYS, V18, P45
  • [3] BARANCIK M, 1995, GEN PHYSIOL BIOPHYS, V14, P171
  • [4] SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance
    Barancík, M
    Bohácová, V
    Kvackajová, J
    Hudecová, S
    Krizanová, O
    Breier, A
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (01) : 29 - 36
  • [5] BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110
  • [6] Bohácová V, 2000, PHYSIOL RES, V49, P447
  • [7] Breier A, 2000, NEOPLASMA, V47, P100
  • [8] Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers
    Castro, AF
    Horton, JK
    Vanoye, CG
    Altenberg, GA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) : 1723 - 1733
  • [9] PHOSPHORYLATION BY PROTEIN-KINASE-C AND CYCLIC-AMP-DEPENDENT PROTEIN-KINASE OF SYNTHETIC PEPTIDES DERIVED FROM THE LINKER REGION OF HUMAN P-GLYCOPROTEIN
    CHAMBERS, TC
    POHL, J
    GLASS, DB
    KUO, JF
    [J]. BIOCHEMICAL JOURNAL, 1994, 299 : 309 - 315
  • [10] CHAMBERS TC, 1992, MOL PHARMACOL, V41, P1008